Published in Epidemiology on January 01, 2001
Inflammation and cancer. Nature (2002) 53.78
Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol (2009) 9.41
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88
Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20
Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Inflammatory cells and cancer: think different! J Exp Med (2001) 2.42
Exposure-measurement error is frequently ignored when interpreting epidemiologic study results. Eur J Epidemiol (2006) 1.93
A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer (2003) 1.88
Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol (2008) 1.83
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst (2014) 1.50
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest (2001) 1.45
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care (2012) 1.42
Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta (2008) 1.36
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol (2011) 1.34
Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol (2002) 1.30
Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res (2008) 1.25
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity. Cancer Prev Res (Phila) (2012) 1.11
Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer (2004) 1.10
Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) (2011) 1.08
Early neoplastic progression is complement independent. Neoplasia (2005) 1.07
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One (2013) 1.01
Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study. Br J Cancer (2010) 0.98
Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr (2013) 0.96
Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma. World J Gastroenterol (2003) 0.95
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer (2011) 0.94
Role of TLR2-dependent inflammation in metastatic progression. Ann N Y Acad Sci (2011) 0.94
Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium. Toxicol Appl Pharmacol (2008) 0.92
Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One (2012) 0.89
Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology (2008) 0.88
Recurrent antibiotic exposure may promote cancer formation - Another step in understanding the role of the human microbiota? Eur J Cancer (2015) 0.88
Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells. Dig Dis Sci (2005) 0.87
SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J Gastroenterol (2011) 0.86
Effect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomas. Cancer Prev Res (Phila) (2011) 0.86
Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory disease. Int J Mol Sci (2014) 0.85
Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer (2010) 0.85
Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol (2015) 0.83
Mechanisms underlying aspirin-mediated growth inhibition and apoptosis induction of cyclooxygenase-2 negative colon cancer cell line SW480. World J Gastroenterol (2008) 0.83
Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf (2014) 0.82
Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps. Cancer Prev Res (Phila) (2011) 0.81
Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis. World J Gastroenterol (2005) 0.81
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol (2014) 0.81
Prevention of colorectal cancer and dietary management. Chin Clin Oncol (2013) 0.80
Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Medicine (Baltimore) (2016) 0.79
Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol (2012) 0.79
Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study. PLoS Med (2016) 0.78
Analgesic medication use and risk of epithelial ovarian cancer in African American women. Br J Cancer (2016) 0.78
Concept of chemoprevention in colorectal cancer. World J Gastrointest Oncol (2009) 0.78
Two-dimensional polyacrylamide gel electrophoresis analysis of indomethacin-treated human colon cancer cells. World J Gastroenterol (2005) 0.78
Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.77
Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis. Carcinogenesis (2014) 0.77
Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer. World J Gastroenterol (2015) 0.77
Rheumatology and musculoskeletal medicine. Br J Gen Pract (2004) 0.77
Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1). Vet J (2007) 0.77
Clinical implication of serosal change in pathologic subserosa-limited gastric cancer. World J Surg (2012) 0.77
Proton pump inhibitors on pancreatic cancer risk and survival. Cancer Epidemiol (2017) 0.75
Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk. J Natl Cancer Inst (2015) 0.75
Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies. Cancer Causes Control (2016) 0.75
A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells. BMC Cancer (2014) 0.75
CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomed Rep (2016) 0.75
Colorectal cancer among users of aspirin and non-steroidal antiinflammatory drugs. Epidemiology (2001) 0.75
Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK. PLoS One (2013) 0.75
[Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]. Wien Med Wochenschr (2003) 0.75
Targeting Inflammation to Improve Tumor Drug Delivery. Trends Cancer (2017) 0.75